MarketBeat reported on the stock performance of Allarity Therapeutics, Inc. on September 1, 2026.
1 report, 1 independent
Updated Sep 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat reported on the stock performance of Allarity Therapeutics, Inc. on September 1, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
MarketBeat
American personal finance blog
Related events
- MarketBeat reported an average stock rating for Superior Group of Companies.
- MarketBeat provided stock performance data and analyst recommendations for Regeneron Pharmaceuticals and IDEAYA Biosciences.
- MarketBeat reported on the financial performance of Donnelley Financial Solutions.
- Analyst ratings published on MarketBeat for Monopar Therapeutics, which trades on the Nasdaq stock exchange.
- MarketBeat aggregated analyst recommendations and price targets for BioMarin Pharmaceutical and Abeona Therapeutics Inc.